CORTCorcept Therapeutics

Median target
$161
calls from the last 12 months
Implied return
+40.2%
median target vs. price
Coverage
6 analysts · 6 calls
updated in the last 12 months
Consensus
5/0/1+4 net
Buy / Hold / Sell

Which analysts are behind CORT's consensus?

See every current rating, price target and the analysts' track records for Corcept Therapeutics — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 6 analysts with calls on CORT updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

CORT elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-16InsidersVieira Roberto WandenkolkPresident, OncologyInsider sale296 sh @ $100.82 · planned trade$30K
2026-09-15InsidersWilson James NDirectorInsider sale6.8K sh @ $110.27 · planned trade$750K
2026-09-15InsidersWilson James NDirectorInsider sale2.8K sh @ $111.70 · planned trade$313K
2026-09-15InsidersWilson James NDirectorInsider sale400 sh @ $110.84 · planned trade$44K
2026-09-14InsidersLyon Joseph DouglasSee RemarksInsider sale7.8K sh @ $113.32 · planned trade$885K
2026-09-14InsidersLyon Joseph DouglasSee RemarksInsider sale2.2K sh @ $114.12 · planned trade$250K
2026-09-02InsidersVieira Roberto WandenkolkPresident, OncologyInsider sale23.8K sh @ $110.70 · planned trade$2.6M
2026-09-02InsidersVieira Roberto WandenkolkPresident, OncologyInsider sale23.6K sh @ $109.35 · planned trade$2.6M
2026-09-02InsidersVieira Roberto WandenkolkPresident, OncologyInsider sale5.6K sh @ $114.58 · planned trade$644K
2026-09-02InsidersVieira Roberto WandenkolkPresident, OncologyInsider sale1.6K sh @ $113.72 · planned trade$183K

More: insider activity · executive branch · trending